BIO

Randall T. Peterson, PhD is a chemical biologist whose research utilizes high-throughput screening technologies to discover new drug candidates for cardiovascular and nervous system disorders.  Unlike conventional drug discovery programs that utilize simplified, in vitro assays, the Peterson lab screens using living zebrafish, ensuring that the drug candidates discovered are active in vivo.  Several of the compounds discovered by the Peterson laboratory have become widely used research tools or preclinical drug candidates.

Dr. Peterson received his PhD from Harvard University where he studied as a Howard Hughes Medical Institute predoctoral fellow in the laboratory of Stuart Schreiber.  He completed a postdoctoral fellowship with Mark Fishman at Massachusetts General Hospital. Dr. Peterson spent 14 years as a faculty member at Harvard University where he was the Charles Addison and Elizabeth Ann Sanders Chair in Basic Science at Harvard Medical School, Scientific Director of the MGH Cardiovascular Research Center, and Senior Associate Member of the Broad Institute.  In 2017 he moved to the University of Utah as L.S. Skaggs Presidential Endowed Professor and Dean of the College of Pharmacy.

INSTITUTIONAL APPOINTMENTS

  • Professor
    Pharmacology and Toxicology1 Jan 2017 - present

ACADEMIC POSITIONS

  • Professor - Pharmacology & Toxicology
    University Of Utah, College Of Pharmacy, United States2 Jan 2017 - present

NON-ACADEMIC POSITIONS

  • L. S. Skaggs Presidential Endowed Chair and Dean
    University Of Utah, College Of Pharmacy, United States2 Jan 2017 - present

DEGREES

  • BS, Molecular Biology
    Brigham Young University, Provo, United States
  • PhD, Biochemistry
    Harvard University, United States

POSTGRADUATE TRAINING

  • Postdoctoral Training, Research Fellow in Medicine
    Cardiovascular Research Center, Massachusetts General Hospital, United States
  • Postdoctoral Training, Research Fellow in Medicine
    Harvard Medical School, United States